• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BLIMP1 诱导胰腺癌中的转移性异质性瞬时变化。

BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer.

机构信息

Department of Genetics, Stanford University School of Medicine, Stanford, California.

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.

出版信息

Cancer Discov. 2017 Oct;7(10):1184-1199. doi: 10.1158/2159-8290.CD-17-0250. Epub 2017 Aug 8.

DOI:10.1158/2159-8290.CD-17-0250
PMID:28790031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5628145/
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most metastatic and deadly cancers. Despite the clinical significance of metastatic spread, our understanding of molecular mechanisms that drive PDAC metastatic ability remains limited. By generating a genetically engineered mouse model of human PDAC, we uncover a transient subpopulation of cancer cells with exceptionally high metastatic ability. Global gene expression profiling and functional analyses uncovered the transcription factor BLIMP1 as a driver of PDAC metastasis. The highly metastatic PDAC subpopulation is enriched for hypoxia-induced genes, and hypoxia-mediated induction of BLIMP1 contributes to the regulation of a subset of hypoxia-associated gene expression programs. These findings support a model in which upregulation of BLIMP1 links microenvironmental cues to a metastatic stem cell character. PDAC is an almost uniformly lethal cancer, largely due to its tendency for metastasis. We define a highly metastatic subpopulation of cancer cells, uncover a key transcriptional regulator of metastatic ability, and define hypoxia as an important factor within the tumor microenvironment that increases metastatic proclivity. .

摘要

胰腺导管腺癌(PDAC)是最具转移性和致命性的癌症之一。尽管转移扩散具有临床意义,但我们对驱动 PDAC 转移能力的分子机制的理解仍然有限。通过生成人类 PDAC 的基因工程小鼠模型,我们发现了具有异常高转移能力的癌细胞短暂亚群。全基因表达谱分析和功能分析揭示了转录因子 BLIMP1 是 PDAC 转移的驱动因素。高度转移性的 PDAC 亚群富含缺氧诱导基因,而缺氧介导的 BLIMP1 诱导有助于调节一组与缺氧相关的基因表达程序。这些发现支持了这样一种模型,即 BLIMP1 的上调将微环境线索与转移性干细胞特征联系起来。PDAC 是一种几乎普遍致命的癌症,主要是由于其转移倾向。我们定义了一个具有高转移性的癌细胞亚群,揭示了转移性能力的关键转录调节因子,并将缺氧定义为肿瘤微环境中的一个重要因素,增加了转移倾向。

相似文献

1
BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer.BLIMP1 诱导胰腺癌中的转移性异质性瞬时变化。
Cancer Discov. 2017 Oct;7(10):1184-1199. doi: 10.1158/2159-8290.CD-17-0250. Epub 2017 Aug 8.
2
Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.小核仁非编码 RNA SNORA23 在人胰腺导管腺癌中上调,调节核膜 2 中富含 spectrin 重复的表达,促进小鼠异种移植肿瘤的生长和转移。
Gastroenterology. 2017 Jul;153(1):292-306.e2. doi: 10.1053/j.gastro.2017.03.050. Epub 2017 Apr 5.
3
Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer.缺氧通过上调胰腺癌中 Smo 转录以非配体依赖的方式激活 hedgehog 信号通路。
Cancer Sci. 2011 Jun;102(6):1144-50. doi: 10.1111/j.1349-7006.2011.01912.x. Epub 2011 Mar 15.
4
Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.靶向miR-224和miR-486的CD40在胰腺导管腺癌进展中的作用
Ann Surg Oncol. 2009 Aug;16(8):2339-50. doi: 10.1245/s10434-009-0531-4. Epub 2009 May 28.
5
Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.GLI的调控是BET溴结构域在胰腺癌生长和肿瘤微环境中发挥作用的基础。
Clin Cancer Res. 2016 Aug 15;22(16):4259-70. doi: 10.1158/1078-0432.CCR-15-2068. Epub 2016 May 11.
6
Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma.水平调节胰腺导管腺癌中的转移异质性。
Cancer Discov. 2022 Feb;12(2):542-561. doi: 10.1158/2159-8290.CD-20-1826. Epub 2021 Sep 22.
7
Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.MTSS1的缺失导致胰腺癌转移潜能增加。
Oncotarget. 2017 Mar 7;8(10):16473-16487. doi: 10.18632/oncotarget.14869.
8
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.脂质运载蛋白-2通过调节肿瘤微环境中的炎症促进胰腺导管腺癌。
Cancer Res. 2017 May 15;77(10):2647-2660. doi: 10.1158/0008-5472.CAN-16-1986. Epub 2017 Mar 1.
9
Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.缺氧而非常氧通过上调胰腺癌中RBPJ和类MAML3促进Smoothened转录。
Cancer Lett. 2016 Feb 28;371(2):143-50. doi: 10.1016/j.canlet.2015.11.012. Epub 2015 Nov 30.
10
The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.新型KLF4/MSI2信号通路调控胰腺癌的生长和转移。
Clin Cancer Res. 2017 Feb 1;23(3):687-696. doi: 10.1158/1078-0432.CCR-16-1064. Epub 2016 Jul 22.

引用本文的文献

1
Hypoxia-induced metastatic heterogeneity in pancreatic cancer.缺氧诱导的胰腺癌转移异质性
bioRxiv. 2025 Aug 29:2025.08.26.672389. doi: 10.1101/2025.08.26.672389.
2
FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development.FGFR2缺失可阻断胰腺导管腺癌的发展。
Cancer Res. 2025 Jun 2;85(11):1960-1977. doi: 10.1158/0008-5472.CAN-24-4576.
3
Tumour hypoxia in driving genomic instability and tumour evolution.肿瘤缺氧在驱动基因组不稳定和肿瘤演变过程中的作用。
Nat Rev Cancer. 2025 Mar;25(3):167-188. doi: 10.1038/s41568-024-00781-9. Epub 2025 Jan 28.
4
AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility.AHNAK2:一种与细胞运动相关的潜在胰腺癌诊断生物标志物。
Sci Rep. 2025 Jan 23;15(1):2934. doi: 10.1038/s41598-025-87337-5.
5
Establishment and Verification of a Novel Gene Signature Connecting Hypoxia and Lactylation for Predicting Prognosis and Immunotherapy of Pancreatic Ductal Adenocarcinoma Patients by Integrating Multi-Machine Learning and Single-Cell Analysis.建立和验证一种新的基因特征,连接缺氧和乳糖化,通过整合多机器学习和单细胞分析预测胰腺导管腺癌患者的预后和免疫治疗。
Int J Mol Sci. 2024 Oct 17;25(20):11143. doi: 10.3390/ijms252011143.
6
Development and validation of a CT-based radiomics model to predict survival-graded fibrosis in pancreatic ductal adenocarcinoma.基于CT的放射组学模型的开发与验证,用于预测胰腺导管腺癌的生存分级纤维化。
Int J Surg. 2025 Jan 1;111(1):950-961. doi: 10.1097/JS9.0000000000002059.
7
Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients.鉴定与舒尼替尼耐药相关的微小 RNA 及其靶基因在透明细胞肾细胞癌患者中的作用。
Int J Mol Sci. 2024 Jun 22;25(13):6881. doi: 10.3390/ijms25136881.
8
The glutathione S-transferase Gstt1 drives survival and dissemination in metastases.谷胱甘肽 S-转移酶 Gstt1 驱动转移中的存活和扩散。
Nat Cell Biol. 2024 Jun;26(6):975-990. doi: 10.1038/s41556-024-01426-7. Epub 2024 Jun 11.
9
Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer.转移性肝癌中不同异常可变剪接的分子靶点及机制
World J Clin Oncol. 2024 Apr 24;15(4):531-539. doi: 10.5306/wjco.v15.i4.531.
10
Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor.染色质重塑相关蛋白PRDM1促进胃癌增殖,溴结构域抑制剂可对其产生抑制作用。
J Pers Med. 2024 Feb 20;14(3):224. doi: 10.3390/jpm14030224.

本文引用的文献

1
A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo.一种定量和多重方法,用于揭示体内肿瘤抑制的适应性景观。
Nat Methods. 2017 Jul;14(7):737-742. doi: 10.1038/nmeth.4297. Epub 2017 May 22.
2
Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis.转移性肺癌状态的分子定义揭示了一个可靶向的CD109- Janus激酶-信号转导和转录激活因子轴。
Nat Med. 2017 Mar;23(3):291-300. doi: 10.1038/nm.4285. Epub 2017 Feb 13.
3
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis.胰腺癌进展过程中的表观基因组重编程将合成代谢性葡萄糖代谢与远处转移联系起来。
Nat Genet. 2017 Mar;49(3):367-376. doi: 10.1038/ng.3753. Epub 2017 Jan 16.
4
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer.胰腺癌个体患者转移灶中已知驱动基因突变的异质性有限。
Nat Genet. 2017 Mar;49(3):358-366. doi: 10.1038/ng.3764. Epub 2017 Jan 16.
5
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.基于基因组重排模式的胰腺癌进化新模型。
Nature. 2016 Oct 20;538(7625):378-382. doi: 10.1038/nature19823. Epub 2016 Oct 12.
6
Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers.Kras 驱动型癌症中杂合性缺失后 p53 的克隆动态。
Nat Commun. 2016 Sep 2;7:12685. doi: 10.1038/ncomms12685.
7
Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system.生发中心缺氧与缺氧反应系统对抗体质量的调节
Nature. 2016 Sep 8;537(7619):234-238. doi: 10.1038/nature19334. Epub 2016 Aug 8.
8
Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.基于图像的胰腺腺癌治疗抗性检测与靶向治疗
Nature. 2016 Jun 16;534(7607):407-411. doi: 10.1038/nature17988. Epub 2016 Jun 6.
9
Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation.转录因子Blimp-1在协调浆细胞分化中的多功能作用。
Nat Immunol. 2016 Mar;17(3):331-43. doi: 10.1038/ni.3349. Epub 2016 Jan 18.
10
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.上皮-间质转化对胰腺癌转移并非必需,但可诱导其产生化疗耐药性。
Nature. 2015 Nov 26;527(7579):525-530. doi: 10.1038/nature16064. Epub 2015 Nov 11.